Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Myopic Choroidal Neovascularization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Not applicableNot Yet RecruitingNCT07009574
What this trial is testing

The Treatment Burden of Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden
Policlinico Gaspare Rodolico - San Marco Catania 100
Testing effectiveness (Phase 2)Study completedNCT01423149
What this trial is testing

Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Choroidal NeovascularizationMyopia, Degenerative
Mateon Therapeutics 23
Large-scale testing (Phase 3)Study completedNCT00370786
What this trial is testing

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Who this might be right for
Choroidal Neovascularization
Shahid Beheshti University of Medical Sciences 31
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Post-approval studies (Phase 4)UnknownNCT02033018
What this trial is testing

Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Retinal Neovascularization
Instituto de Olhos de Goiania 20
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Not applicableStudy completedNCT03971162
What this trial is testing

Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal Neovascularisation
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Not applicableStudy completedNCT04524910
What this trial is testing

Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

Who this might be right for
Myopic Choroidal Neovascularization
Bayer 28
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableStudy completedNCT02260687
What this trial is testing

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Bayer 353
Post-approval studies (Phase 4)Study completedNCT00797992
What this trial is testing

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal Neovascularization
Instituto de Olhos de Goiania 5
Not applicableStudy completedNCT03070717
What this trial is testing

High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)

Who this might be right for
Pathologic Myopia
Novartis Pharmaceuticals 153
Large-scale testing (Phase 3)Study completedNCT01217944
What this trial is testing

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Pathological Myopia
Novartis Pharmaceuticals 277
Not applicableStudy completedNCT03963596
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 122
Post-approval studies (Phase 4)Study completedNCT03042871
What this trial is testing

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 54